The cyclin-dependent kinase inhibitor CR8 acts as a molecular glue compound by inducing the formation of a complex between CDK12–cyclin K and DDB1, which results in the ubiquitination and degradation of cyclin K.
- Mikołaj Słabicki
- Zuzanna Kozicka
- Benjamin L. Ebert